We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Leica Microsystems Acquires Labindia’s Microscopy and Histopathology Divisions

By LabMedica International staff writers
Posted on 15 Nov 2011
In a move set to boost growth with a local presence in India, Leica Microsystems (Wetzlar, Germany) acquired the microscopy and histopathology divisions of Labindia Instruments Pvt. More...
Ltd. (Thane, India).

This move comes after more than 20 years during which Labindia has successfully distributed Leica’s products in India. Over 130 associates from Labindia have transferred to Leica Microsystems to sustain continuity for existing customers who will continue to benefit from Labindia’s experience of their needs and applications. The acquisition is the culmination of a long partnership, and supports Leica Microsystems’ strategy to expand its operations in India.

“Leica Microsystems’ expansion of its commercial operations in India creates extended opportunities for interaction, collaboration, and innovation to benefit all of our customers in the life sciences, industrial laboratories and hospitals for both diagnostics and surgery,” explains Arnd Kaldowski, president Leica Microsystems. “This acquisition will enable closer contact with our customers so that we can better support them in their day-to-day work.”

Vijay Bibikar, director Labindia, commented, “We are convinced that at this point in time this agreement is a logical further step in the long history of close cooperation between Labindia and Leica Microsystems and that it will be beneficial to all our customers.” Says Kaldowski: “We highly appreciate the work that our partner Labindia has done driving our business in India to its present high level. We are excited about the future potential of the Indian market and the potential to help our customers to meet with their professional challenges.”

Leica Microsystems is a world leader in microscopes and scientific instruments. Leica Microsystems is organized in four divisions: the Life Science Division, Industry Division, Biosystems Division, and Medical Division. Leica Microsystems’ Biosystems Division, also known as Leica Biosystems offers histopathology laboratories a product range for each step in histology and for high levels of productivity in the working processes. The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries, and an international network of dealers.

Related Links:
Leica Microsystems
Labindia Instruments


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.